ADVENZYMESAdvanced Enzyme Technologies Ltd

    Advanced Enzyme Technologies buys back 40,000 shares on 14 Oct, taking its total to 19.54 lakh

    • Corporate action

    Blacklitt Research2 min read

    Advanced Enzyme Technologies Limited has told the exchanges that it bought back 40,000 of its equity shares of ₹2 face value on 14 Oct 2026, under its open-market buyback through the stock exchange mechanism. The filing is the company’s daily report under Regulation 18(i) of the SEBI buyback regulations.

    The shares were bought on the NSE through Emkay Global Financial Services Limited, with nothing bought on the BSE, at an average price of ₹268.00 per share, excluding transaction costs. The cumulative number of shares bought back up to the previous day was 19,13,660, so the total as of 14 Oct 2026 is 19,53,660 shares.

    The closed-out quantity fields in the report are left blank. The company says the details will also be made available on its website and on the websites of the stock exchanges.

    Inference

    A daily buyback report shows how many shares a company has repurchased from the market so far. The company bought 40,000 shares on this day, a little less than 2.1% of the total bought back to date.

    The filing does not state the total size of the buyback or how much of it has been completed. That information is in the company’s public announcement for the offer, which is not part of this report.

    Reference: Original filing (PDF)

    Disclaimer:

    The information available on this article is provided for education and informational purposes only. It does not constitute or provide financial, investment or trading advice and should not be construed as an endorsement of any specific stock or financial strategy in any form or manner. We do not make any representations or warranties regarding the quality, reliability, or accuracy of the information provided. This website may contain links to third-party content. We are not responsible for the content or accuracy of these external sources and do not endorse or verify the information provided by third parties. We are not liable for any decisions made or actions taken based on the information provided on this website.

    Related posts